Keep updated with the latest MDPP news via our newsletter.

The new round of funding for the $22.3 million Biomedical Translation Bridge (BTB) program is now open.

The third round of the BTB program (COVID-19 Response) is open from Monday 18 May to Monday 1 June 2020.

In this specific COVID-19 call, the BTB Program can provide up to $1million to support eligible organisations develop medical devices, diagnostics, prophylactic or therapeutic approaches that will achieve an impact on the global response to the pandemic in less than 12 months.

Funding will support Australian small and medium enterprises, medical research institutes and universerities conducting COVID-19 related research projects.

Applicants will be required to provide one-to-one matching funding in the form of cash to be eligible.

For full details of the guidelines and application process visit the MTPConnect website.

MTPConnect is delivering the BTB program in partnership with BioCurate (Melbourne and Monash Universities), UniQuest (University of Queensland), the Medical Device Partnering Program (led by Flinders University) and the Bridge and BridgeTech programs (Queensland University of Technology).

Australia’s first face mask testing facility will be established in Adelaide – harnessing the research expertise of Flinders University and UniSA - to support the production of millions of respirator and surgical masks by the Detmold Group to help stop the spread of COVID-19. 

Premier Steven Marshall said the State Government’s strong plan to protect South Australians during the coronavirus pandemic was fostering the development of critical local medical capability.

“Making and testing respirators and surgical masks in Adelaide is exactly the type of innovative response required to provide Australia with the equipment needed to halt the spread of COVID-19 and save lives,” said Premier Marshall.

“This is an outstanding example of government, universities and business coming together to work in the national interest in the most challenging of times”

Minister Wade said the establishment of testing facilities at local universities for locally made respirators and surgical masks will provide ongoing assurance to the public of the quality and safety of equipment being used in our hospitals.

I commend the initiative of Flinders University and the University of South Australia for recognising the important role they can play to improve the delivery of this vital protective medical equipment to Australian health workers,” said Minister Wade.

“The State Government, Flinders University and the University of South Australia are collaborating to rapidly respond to the need for an onshore facility to test the locally made medical equipment that will start rolling off the production line in May,” Minister for Innovation and Skills David Pisoni said.

“In these unprecedented circumstances, science, research, innovation and collaboration have never been more important.

“The State / Marshall Government is determined to do everything we can to support industry and research to fight COVID-19 and minimise the impact on our state.

“A $450,000 grant through the Research Commercialisation and Startup Fund will support the South Australian facility, which will be established using laboratories at Flinders Tonsley and UniSA Mawson Lakes, providing new capability for Australia and the state.

“Face masks such as the respirator P2/N95 and level 3 surgical masks need to be tested to strict manufacturing standards to protect frontline health workers, and usually testing is undertaken in the United States, taking around three weeks.

“China produces most of the global supply of face masks, however this has been significantly disrupted because of the COVID-19 pandemic.

“Last month, the State and Commonwealth Governments commissioned Detmold, a South Australian packaging company, to establish a respirator (P2/N95 masks) and surgical mask (Level 3) manufacturing capability in Brompton producing 45 million face masks for SA Health and 100 million for the Federal Government’s National Medical Stockpile.

“Production is expected to start in May 2020, and at full capacity should produce more than 20 million masks each month for local and national markets.

“With this new testing facility, we will be able to deliver this medical equipment to hospitals within weeks, substantially faster than previously.”

Professor Karen Reynolds, Director Medical Device Partnering Program and Dean (Research) College of Science and Engineering Flinders University, said the facility will bring together an impressive array of research strength to ensure the protective equipment used by South Australia’s health professionals keeps them safe.

“In order to protect our vital hospital staff, face masks have to meet rigorous standards – they need to filter out bacteria, resist blood, withstand wear and tear, and yet still be easy to breathe through,” she said.

Professor Caroline McMillen, Chief Scientist of South Australia said it was excellent to see how a team of outstanding researchers in SA had mobilised to collaborate with industry to support the community fight against COVID-19.

“It is this type of collaboration that delivers new ways of thinking to drive the innovation required not only to address an immediate challenge but to build the capability and resilience that is important for the future,” she said.

CEO of Detmold Group, Alf Ianniello said these face masks need to be tested to strict Australian standards to protect frontline health workers and the testing is usually undertaken in the US.

“Given the critical need for Australian manufacturing of masks to ensure adequate supply of personal protective equipment for the medical industry, we cannot afford to wait for our surgical masks to be tested overseas.”

The new round of funding for the $22.3 million Biomedical Translation Bridge (BTB) program is now open.

An initiative of the Medical Research Future Fund (MRFF) and operated by MTPConnect, the BTB program is offering up to $1 million to support development and commercialisation of new biological, pharmaceutical, medical and health technology projects.

This is the second round of the BTB program. Round one, announced in December 2019, saw eight projects selected to share in funding of $5.9 million following a competitive application process.

MTPConnect Managing Director and CEO, Dr Dan Grant, says the BTB program is a unique opportunity for Australian innovators to take their research to the next stage along the translation and commercialisation pathway.

“We’re looking to support SMEs and research organisations conducting research projects that provide innovative solutions in any disease area using any therapeutic modality or medical technology," Dr Grant adds.

“With applications only open for three weeks, from Monday, the Australian research community needs to move quickly to take advantage of the substantial funding on offer.”

MTPConnect is delivering the BTB program in partnership with BioCurate (Melbourne and Monash Universities), UniQuest (University of Queensland), the Medical Device Partnering Program (led by Flinders University) and the Bridge and BridgeTech programs (Queensland University of Technology).

The BTB program is uniquely positioned to provide applicants with expert mentoring from these partners, that provides scientific expertise and commercial acumen to support projects in their translation to proof of concept.

“The successful projects we invest in through the BTB program will lead to new therapies, technologies and medical devices to improve the health of Australians and deliver real impact to people all over the world,” Dr Grant explains.

Opening Monday 17 February, applications to the BTB program will be open until 5:00PM (AEDT) on Friday, 6 March 2020. Details can be found at the BTB page.

MDPP Director Prof Karen Reynolds with engineering staff

The Medical Device Partnering Program (MDPP), founded by Flinders University, has been named a partner in the Australian Government’s $32 million Researcher Exchange and Development with Industry (REDI) initiative, through the Medical Research Future Fund.

To deliver the program, MTPConnect is partnering with research, training and industry organisations to deploy an integrated, three-pillar plan driving skills development and workforce training that brings together researchers, clinicians, industry and the entrepreneurial ecosystem.

Announced yesterday (5 February 2020) by Minister for Health Greg Hunt MP, the $32 million investment will boost Australia’s success in turning innovative health and medical research ideas into commercial reality.

MDPP Director Professor Karen Reynolds has welcomed the opportunity.

“We are excited to expand our relationship with MTPConnect through the announcement of the REDI program and to continue to support the medtech sector across Australia,” she said.

Read more about the REDI announcement on the MTPConnect website.

 

MDPP VIC 1st birthday

This month, the MDPP Victoria team celebrated their first birthday, and we want to thank all of our supporters and collaborators who have helped make the first year such a success. 

During this first year they have hit the ground running and have:

  • Established an expert team
  • Leveraged the expertise of our Victorian Steering Committee of industry leaders from the sector
  • Consulted on over 80 ideas for new medical technologies
  • Held 25 workshops, bringing together industry and research experts to provide input on these innovations
  • Approved funding for nine projects

We could not have done any of this without the valued support of many. 

First we’d like to thank LaunchVic, Victoria’s startup agency, for their support to deliver the Program in Victoria.

Our Victorian partners who have contributed expertise, facilities and guidance: Swinburne University, St. Vincent's Hospital, University of Melbourne, RMIT University, Melbourne Centre for Nanofabrication, Monash University, La Trobe University, Baker Institute, CSIRO, Bionics Institute and BioMedVic.

Our National MDPP Sponsors: Design + Industry, FB Rice, Madderns, Motherson Innovations and Phillips Ormonde Fitzpatrick for their support to help build the med-tech industry in Australia.

And to the many, many organisations and individuals who have provided their time and expertise during workshops and client consultations.

We look forward to making an even greater impact during 2020, supporting more ideas for medical or assistive devices. So if you have an idea for a new medical technology and need R&D assistance, connect with us today. Or if you know of someone who may benefit from MDPP assistance, please refer them to our website: www.mdpp.org.au

Again, thank you to everyone who has supported us in our vision for Australia to lead the world in med-tech innovation and drive solutions to advance healthcare globally.

 

 

BTB Logo Master R4 rgb BTB Powered By MTPConnect logolockup

 

12 December 2019

Acting Health Minister Alan Tudge announced $5.9 million will be provided to fund 8 early stage projects through round 1 of the MRFF’s Biomedical Translation Bridge (BTB) Program.

Dr Dan Grant, Managing Director and CEO of MTPConnect, said the successful projects will cover new medical technologies and novel therapies to address unmet clinical needs.

“We believe these research projects could eventually play a vital role in tackling a number of major challenges for our health sector and contribute towards delivering improved health outcomes for Australians of all ages,” said Dr Grant.

The Biomedical Translation Bridge (BTB) program aims to help Australia move more cutting-edge ideas and breakthrough discoveries swiftly towards proof-of-concept and commercialisation, while stimulating collaboration between the research, industry and technology sectors to maximise entrepreneurship and idea potential.

Medical Connect is one of the first projects to come through the Victorian-MDPP, thanks to support from LaunchVic. Working with Swinburne University’s Centre for Design Innovation the project is to design and test a new aircraft seating design that could make transporting patients by air accessible and affordable.

 

Medical Connect with team from Swinburne

[Image courtesy of Swinburne: The Swinburne and Medical Connect team (L to R): Matthew Blythman, Andrew Heath, Linda Heath, Dr Boris Eisenbart, Matt Richardson, Dr Benedikt Lux] 

Medical Connect co-founder, Mr Andrew Heath says the assistance of the MDPP, combined with the input of Swinburne’s expert researchers, provided the best chance to develop and commercialise the project. 

“What we liked most about the MDPP opportunity was partnering with Swinburne and researchers from its Centre for Design Innovation who have significant industry experience and technical knowledge. 

“They could help us to test assumptions and provide technical knowledge to convert our idea into a physical prototype that we can take to industry and the market.” 

Click here to read the full story by the Swinburne media team.

 

MDPP Victoria supported by

LaunchVicLogo Horizontal CMYK

You may also be interested in: